|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2002-1-4
|
|
pubmed:abstractText |
To study the inhibitory effect of CH50, a recombinant polypeptide consisting of 2 binding domains of human fibronectin, on the growth of B16/F1 melanoma in mice.
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0253-3766
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
416-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11776614-Animals,
pubmed-meshheading:11776614-Antineoplastic Agents,
pubmed-meshheading:11776614-Camptothecin,
pubmed-meshheading:11776614-Dose-Response Relationship, Drug,
pubmed-meshheading:11776614-Fibronectins,
pubmed-meshheading:11776614-Melanoma, Experimental,
pubmed-meshheading:11776614-Mice,
pubmed-meshheading:11776614-Mice, Inbred C57BL,
pubmed-meshheading:11776614-Recombinant Proteins
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
[The inhibitory effect of recombinant fibronectin polypeptide CH50 on the growth of B16 melanoma].
|
|
pubmed:affiliation |
Department of Medical Molecular Biology, Tongji Medical University, Wuhan 430030.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|
